You're contacting media contact of this press release
Title: CoreAge Rx Raises the Bar on Medication Delivery With Free 2-Day Shipping, Temperature-Controlled Packaging, and a Fully Doorstep-to-Patient Experience
United States, 27th Feb 2026 - CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, has built a medication delivery model that independent reviewers and patients consistently describe as one of the strongest in the GLP-1 telehealth space. Free 2-day shipping on every order, temperature-controlled packaging, discreet delivery, and a streamlined fulfillment process that begins the moment a physician approves a prescription — these are the features that separate CoreAge Rx from providers who treat shipping as an afterthought.For patients managing a GLP-1 program, medication delivery is not a minor convenience. Compounded Semaglutide and Tirzepatide are peptide medications that must be kept cold throughout the journey from pharmacy to patient. A breakdown in the cold chain — whether due to improper packaging, slow transit, or a carrier delay — can compromise the medication before it ever reaches the patient. CoreAge Rx has structured its entire fulfillment process around preventing exactly that.Free 2-Day Shipping on Every Order, No ExceptionsCoreAge Rx provides complimentary 2-day shipping on every prescription, at every dose level, with no minimum order and no shipping tier that patients have to qualify for. This is included as a standard part of the program — not an upgrade, not a promotional offer, and not subject to a membership fee. Many competing providers charge between $15 and $30 per shipment for standard delivery, with expedited options priced higher still. CoreAge Rx absorbs that cost entirely, making the flat monthly program fee the only charge patients receive.GLP-1 News Today, which ranked CoreAge Rx first among more than 12 telehealth platforms evaluated for Tirzepatide access, specifically cited free 2-day...
This press release is issued by King Newswire